1.The pathogenesis features of ulcerative colitis and the pathogenetic theory of "toxin impairing intestine collateral".
Chinese Journal of Integrated Traditional and Western Medicine 2013;33(3):410-414
Ulcerative colitis (UC), a kind of chronic nonspecific intestinal inflammation with unknown etiology, is very difficult to cure. It recurs often and even is accompanied with parenteral lesion. It has been rated as one of contemporary refractory diseases by World Health Organization. The author combines the pathological mechanisms of UC with the poison-evil theory and the collateral disease theory, and puts forward that "toxin impairing intestine collateral" pathogenesis theory. We believe that longer accumulation of damp-heat stasis toxin that damages the intestine collateral is the key cause for recurrence and relapses of UC. We explained its theory foundation in terms of pathogenesis of UC from Chinese medicine and modern medicine. The "toxin impairing intestine collateral" theory might perfect the syndrome typing system for UC, and provide a new way of thinking for treating UC.
Colitis, Ulcerative
;
diagnosis
;
etiology
;
pathology
;
Humans
;
Medicine, Chinese Traditional
;
methods
2.Treatment of Steroid Refractory Ulcerative Colitis.
The Korean Journal of Gastroenterology 2006;48(4):290-291
No abstract availble.
Colitis, Ulcerative/complications/*diagnosis/pathology
;
Colonoscopy
;
Female
;
Humans
;
Intestinal Obstruction/*diagnosis/etiology/pathology
;
Middle Aged
3.A Case of Pulmonary Thromboembolism in Active Ulcerative Colitis.
Byoung Do PARK ; Hyung Gil KIM ; Hyun Jung JUNG ; Yong Jun CHOI ; Sang Gu KIM ; Soo Han KIM ; Gye Sug KWON ; Yong Woon SHIN
The Korean Journal of Gastroenterology 2009;53(1):48-52
Inflammatory bowel disease often involves extra-intestinal organs. Cerebral thrombosis, portal vein thrombosis and pulmonary thrombosis have been reported. Deep vein thrombosis and pulmonary thromboembolism are significant causes of mortality in patients with inflammatory bowel disease. A 48-year-old woman was diagnosed as inflammatory bowel disease on colonoscopy and histology. We used hydrocortisone and mesalazine for the treatment of disease. Nineteen days later, she complained of abrupt dyspnea. Pulmonary CT angiography revealed a thromboembolism in right pulmonary arteries. After the treatment of heparin therapy, follow-up pulmonary CT angiography showed significant improvement of previously thrombosed pulmonary arteries.
Acute Disease
;
Colitis, Ulcerative/complications/*diagnosis
;
Colonoscopy
;
Female
;
Humans
;
Middle Aged
;
Pulmonary Embolism/*diagnosis/etiology/pathology
;
Tomography, X-Ray Computed
4.The Clinical Usefulness of Focally Enhanced Gastritis in Korean Patients with Crohn's Disease.
Cheul Ho HONG ; Dong Il PARK ; Woo Hyuk CHOI ; Jung Ho PARK ; Hong Joo KIM ; Yong Kyun CHO ; Chong Il SOHN ; Woo Kyu JEON ; Byung Ik KIM ; Dong Hoon KIM ; Min Kyung KIM ; Seung Wan CHAE ; Kyoung Bun LEE ; Jin Hee SOHN ; Suk Joong OH
The Korean Journal of Gastroenterology 2009;53(1):23-28
BACKGROUND/AIMS: Focally enhanced gastritis (FEG) has been suggested as a specific diagnostic marker for patients with Crohn's disease (CD). However, the usefulness of FEG for distinguishing CD from ulcerative colitis (UC) is uncertain and the incidence or prevalence of FEG for inflammatory bowel disease (IBD) patients in Korea has not been defined yet. In this study, we investigated the frequency of FEG and other gastric histological abnormalities in Korean patients with CD and UC. METHODS: We evaluated 37 patients with known CD, 43 patients with UC and 41 non-IBD control group; all underwent upper gastrointestinal endoscopy followed by biopsy from the antrum and the body. The pathology of the gastric biopsy specimens and the presence of Helicobacter pylori (H. pylori) were evaluated. FEG was characterized by a focal perifoveolar or periglandular inflammatory cell infiltrates. RESULTS: H. pylori positive gastritis was found in 10 of 37 (27.0%) of CD patients, in 16 of 43 (37.2%) of UC patients, and in 22 of 41 (53.7%) of non-IBD control group (p=0.054). In H. pylori-negative patients, FEG was found in 8 of 27 patients (29.6%) of CD patients, 6 of 27 (22.2%) patients with UC, and 2 of 9 (10.5%) of non-IBD control group (p=0.324). CONCLUSIONS: In H. pylori-negative patients, there was no statistically significant difference in the occurrence of FEG among CD, UC and control groups in Korea.
Adult
;
Colitis, Ulcerative/*diagnosis/etiology/pathology
;
Crohn Disease/*diagnosis/etiology/pathology
;
Female
;
Gastritis/epidemiology/*pathology
;
Gastroscopy
;
Humans
;
Korea/epidemiology
;
Male
;
Middle Aged
;
Upper Gastrointestinal Tract/pathology
5.Atypical clinical manifestations of amebic colitis.
Jung Hwan YOON ; Ji Gon RYU ; Jong Kyun LEE ; Sae Jin YOON ; Hyun Chae JUNG ; In Sung SONG ; Kyoo Wan CHOI ; Chung Yong KIM
Journal of Korean Medical Science 1991;6(3):260-266
Amebic colitis is a disease revealing diverse clinical manifestations and endoscopic gross features and often confused with other types of colitis. In case of misdiagnosis as an idiopathic inflammatory bowel disease or delayed recognition of intestinal amebiasis, an undesirable outcome may occur resulting from erroneous administration of steroids or delayed antiamebic treatment. To demonstrate the pitfalls in the diagnosis and treatment of intestinal amebiasis, 3 cases of amebic colitis with atypical clinical manifestations are presented in this paper. In conclusion, despite the low sensitivities of routine stool examination for parasite and histopathologic confirmation in biopsy specimen, every effort must be made to find amebic trophozoites either in fresh stool or biopsy specimens for prompt and correct diagnosis of amebic colitis when we manage patients with chronic intestinal ulcerations, even though their clinical course and endoscopic findings are not typical of amebiasis. Moreover, following initial successful anti-amebic therapy, more careful clinical, endoscopical, and parasitological follow-up should be done for the early detection of recurrence.
Adult
;
Aged
;
Aged, 80 and over
;
Colitis, Ulcerative/diagnosis
;
Diagnosis, Differential
;
Diarrhea/etiology
;
Dysentery, Amebic/complications/drug therapy/*pathology
;
Female
;
Humans
;
Inflammatory Bowel Diseases/diagnosis
;
Male
;
Middle Aged
7.A Case of Steroid Resistant Autoimmune Hemolytic Anemia in Ulcerative Colitis.
Hyun Jong CHOI ; Su Jin HONG ; Young Jee KIM ; Bong Min KO ; Moon Sung LEE ; Chan Sup SHIM ; Hyun Jung KIM ; Dae Sik HONG
The Korean Journal of Gastroenterology 2008;51(2):137-141
Autoimmunity is thought to play a central role in the pathogenesis of inflammatory bowel disease and associated extraintestinal manifestations. Autoimmune hemolytic anemia associated with ulcerative colitis is a rare occurrence. No more than 50 cases have been described in the international literatures, and only 2 cases reported in Korea. A 29-year-old woman who was diagnosed as ulcerative colitis two years ago was complicated with autoimmune hemolytic anemia, and did not respond to steroid therapy. Ultimately, total colectomy and splenectomy were carried out for the treatment of ulcerative colitis and hemolytic anemia. After the operation, anemia was resolved. We present the case with a review of literature.
Adult
;
Anemia, Hemolytic, Autoimmune/*diagnosis/drug therapy/etiology
;
Colectomy
;
Colitis, Ulcerative/complications/*diagnosis/pathology
;
Drug Resistance
;
Female
;
Humans
;
Splenectomy
;
Steroids/therapeutic use
8.Drug-induced lymphadenitis.
Wei-hua YIN ; Hong-yu ZHANG ; Xue-feng LI ; Ya MA
Chinese Journal of Pathology 2010;39(3):192-194
Adult
;
Anti-Inflammatory Agents, Non-Steroidal
;
adverse effects
;
therapeutic use
;
CD3 Complex
;
metabolism
;
Colitis, Ulcerative
;
drug therapy
;
Diagnosis, Differential
;
Drug Hypersensitivity
;
etiology
;
metabolism
;
pathology
;
Female
;
Gastrointestinal Agents
;
adverse effects
;
therapeutic use
;
Humans
;
Immunoblastic Lymphadenopathy
;
metabolism
;
pathology
;
Ki-1 Antigen
;
metabolism
;
Lymphadenitis
;
chemically induced
;
metabolism
;
pathology
;
Lymphoma, Large-Cell, Anaplastic
;
metabolism
;
pathology
;
Lymphoma, T-Cell
;
metabolism
;
pathology
;
Receptors, Complement 3d
;
metabolism
;
Sulfasalazine
;
adverse effects
;
therapeutic use